Elsevier

Schizophrenia Research

Volume 6, Issue 1, December 1991, Pages 41-48
Schizophrenia Research

Alterations in phencyclidine and sigma binding sites in schizophrenic brains: Effects of disease process and neuroleptic medication

https://doi.org/10.1016/0920-9964(91)90019-NGet rights and content

Abstract

The specific binding of [3H]TCP and [3H](+)3-PPP, radioligands which respectively label PCP-NMDA and sigma binding sites was measured in tissue homogenates prepared from dissected areas of control and schizophrenic postmortem brains. [3H]TCP binding was bilaterally increased in orbital frontal cortex (Brodmann area 11) of schizophrenic brains. This finding may be due to an increased glutamatergic innervation of orbital frontal cortex since it parallels our findings of increased [3H]kainate and [3H]D- aspartate binding in this area. In contrast, [3H](+)3-PPP binding was reduced in each of the four brain regions examined. The reductions were greatest in brains from the schizophrenic subjects receiving neuroleptics at the tine of death. Neuroleptics remaining in the brains of these subjects may compete in vitro with [3H](+)3-PPP for binding to the sigma site.

References (42)

  • T.-P. Su

    HR 375: a potential antipsychotic drug that interacts with dopamine D2 receptors and sigma-receptors in the brain

    Neurosci. Lett.

    (1986)
  • M.R. Allen et al.

    Phencyclidine-induced psychosis

    Am. J. Psychiatry

    (1978)
  • O. Aniline et al.

    Phencyclidine: a review and perspectives

    CRC Crit. Rev. Toxicol.

    (1982)
  • N.A. Anis et al.

    The dissociative anesthetics, ketamine and phencyclidine, selectively reduce excitation of central mammalian neurones by N-methyl-aspartate

    Br. J. Pharmacol.

    (1983)
  • F.M. Benes et al.

    Increased vertical axon numbers in cingulate cortex of schizophrenics

    Arch. Gen. Psychiatry

    (1987)
  • L.B. Bigelow et al.

    Corpus callosum thickness in chronic schizophrenia

    Br. J. Psychiatry

    (1983)
  • M.S. Buchsbaum et al.

    Cerebral glucography with positron tomography

    Arch. Gen. Psychiatry

    (1982)
  • B.G. Campbell et al.

    Both the sigma receptor-specific ligand (+)3-PPP and the PCP receptor-specific ligand TCP act in the mouse vas deferens via augmentation of electrical ly evoked norepinephrine release

    Eur. J. Pharmacol.

    (1987)
  • J.M. Dawson et al.

    Lowry method of protein quantification: evidence for photosensitivity

    Anal. Biochem.

    (1984)
  • J.F.W. Deakin et al.

    Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia

    J. Neurochem.

    (1989)
  • J. Fuster

    The Prefrontal Cortex

    (1980)
  • Cited by (96)

    • N-Methyl-D-Aspartate receptor and inflammation in dorsolateral prefrontal cortex in schizophrenia

      2022, Schizophrenia Research
      Citation Excerpt :

      However, our study is in contrast to previous postmortem schizophrenia investigations that report no statistically significant changes in various NMDAR measures in the cortex. Cohorts in previous studies of NMDARs in postmortem cortex consisted of 13–26 schizophrenia cases per group (Kristiansen et al., 2010; Simpson et al., 1991; Akbarian et al., 1996; Beneyto and Meador-Woodruff, 2008; Scarr et al., 2005; Woo et al., 2008a; Dean et al., 2016; Kristiansen et al., 2006; Kornhuber et al., 1989; Dracheva et al., 2001). Here, we investigated multiple NMDAR-related molecular indices in a cohort of 37 cases per diagnostic group (Catts et al., 2016), and we stratified by inflammatory status which increased the effect size in the smaller subgroups.

    • Potential targeting sites in brain and brain tumors

      2022, Nanocarriers for Drug-Targeting Brain Tumors
    • The SIGMAR1 gene is associated with a risk of schizophrenia and activation of the prefrontal cortex

      2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      The chronic administration of the preferential sigma-1 receptor ligand is able to modify levels of several glutamate subunits in the rat PFC (Guitart et al., 2000). Postmortem study comparing normal controls to patients with schizophrenia revealed that schizophrenics have a reduced density of sigma binding sites in the frontal cerebral cortex (Simpson et al., 1991). There is evidence that activation of the PFC during the verbal fluency task, as assessed using multi-channel NIRS, is significantly lower in Pro carriers of the SIGMAR1 gene than in individuals with the Gln/Gln genotype (Takizawa et al., 2009a).

    • Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: Role of sigma-1 receptors

      2009, Brain Research
      Citation Excerpt :

      Further study of the cross-talk between sigma-1 receptors and NMDA receptors in the brain is still necessary. Postmortem human brain studies on brains from schizophrenic patients have indicated that the density of sigma receptors was lower in the temporal cortex (Weissman et al., 1991), but higher in the superior parietal cortex (Shibuya et al., 1992) than in the control tissue, although chronic neuroleptic treatment may contribute to these differences (Simpson et al., 1991; Hashimoto and London, 1994). Furthermore, it is also reported that [3H]nemonapride binding to sigma receptors in the caudate of postmortem brain of schizophrenic patients was significantly decreased as compared with control group (Helmeste et al., 1996).

    View all citing articles on Scopus
    View full text